Cabasag, Sydney .

HRN: 19-63-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
AMPICILLIN 250MG (VIAL)
11/22/2022
11/29/2022
IV
225 Mg
Q6
R/O UTI
Waiting Final Action 
05/11/2023
CEFUROXIME 750MG (VIAL)
05/11/2023
05/17/2023
IV
340mg
Q8H
NKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: